Discover how an emerging technology called tRNA therapy could become the next big thing in genetic disease treatment.

A new study suggests genetic changes allow horses to produce more energy, while minimizing the toll the energy takes on cells ...

A genetic mutation in horses that would typically halt protein production has become a molecular asset. Researchers at Johns ...

Could a gene regulatory network in gut microbes have evolved its elaborate and tightly regulated molecular machinery only to ...

Gene therapy for cystic fibrosis is advancing fast. Explore key biotech players, clinical progress, and its potential to ...

Horses possess a rare genetic peculiarity. This adaptation partly explains their exceptional endurance without compromising ...

“In 10 to 15 percent of human diseases, you have a premature stop codon,” says Castiglione. If horse ancestors found a way to still produce a functional protein, perhaps a similar, equine ...

This can often be achieved by utilizing one or more silent third-codon point mutations within the targeted region, although controls for fortuitous miRNA effects are desirable. Translational ...

Here, we focus narrowly on the Orthocoronavirinae clade and demonstrate models that are powerfully predictive for a human-pathogen phenotype with 76.74% average precision and 85.96% average recall on ...

National Center for Competence in Research (NCCR), Molecular Systems Engineering, 4058 Basel, Switzerland ...